Literature DB >> 18506022

First-line chemotherapy for non-small-cell lung cancer: is there a superior regimen based on histology?

Lawrence H Einhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18506022     DOI： 10.1200/JCO.2008.17.2056

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

1.  Chemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer.

Authors:  Akaash K Mishra; Silvana S Dormi; Alaina M Turchi; Derek S Woods; John J Turchi
Journal:  Biochem Pharmacol       Date:  2014-11-04       Impact factor: 5.858

2.  Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

Authors:  Isamu Okamoto; Keisuke Aoe; Terufumi Kato; Yukio Hosomi; Akira Yokoyama; Fumio Imamura; Katsuyuki Kiura; Tomonori Hirashima; Makoto Nishio; Naoyuki Nogami; Hiroaki Okamoto; Hideo Saka; Nobuyuki Yamamoto; Naoto Yoshizuka; Risa Sekiguchi; Kazuhiro Kiyosawa; Kazuhiko Nakagawa; Tomohide Tamura
Journal:  Invest New Drugs       Date:  2013-03-10       Impact factor: 3.850

3.  Treatment results including more than third-line chemotherapy for patients with advanced non-small cell lung cancer.

Authors:  Seh Jong Park; In Keun Choi; Hee Yun Seo; Hwa Jung Sung; Kyong Hwa Park; Sang Cheul Oh; Jae Hong Seo; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

4.  Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.

Authors:  Takahiro Ota; Keisuke Kirita; Reiko Matsuzawa; Hibiki Udagawa; Shingo Matsumoto; Kiyotaka Yoh; Seiji Niho; Genichiro Ishii; Koichi Goto
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-07       Impact factor: 4.553

5.  Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program.

Authors:  Karynsa Cetin; David S Ettinger; Yong-Jiang Hei; Cynthia D O'Malley
Journal:  Clin Epidemiol       Date:  2011-04-28       Impact factor: 4.790

6.  Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients.

Authors:  Wenting Wu; Huan Li; Huibo Wang; Xueying Zhao; Zhiqiang Gao; Rong Qiao; Wei Zhang; Ji Qian; Jiucun Wang; Hongyan Chen; Qingyi Wei; Baohui Han; Daru Lu
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

7.  Choroid metastases revealing primary clear cell adenocarcinoma of the lung effectively treated with cisplatin and pemetrexed: a case report.

Authors:  Yueh-Shih Chang; Ling Yeung; Liang-Che Chang; Jen-Seng Huang; Kun-Yun Yeh
Journal:  J Med Case Rep       Date:  2013-12-11

8.  The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.

Authors:  Justin Goodwin; Michael L Neugent; Shin Yup Lee; Joshua H Choe; Hyunsung Choi; Dana M R Jenkins; Robin J Ruthenborg; Maddox W Robinson; Ji Yun Jeong; Masaki Wake; Hajime Abe; Norihiko Takeda; Hiroko Endo; Masahiro Inoue; Zhenyu Xuan; Hyuntae Yoo; Min Chen; Jung-Mo Ahn; John D Minna; Kristi L Helke; Pankaj K Singh; David B Shackelford; Jung-Whan Kim
Journal:  Nat Commun       Date:  2017-05-26       Impact factor: 14.919

9.  Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.

Authors:  Qin Qin; Chi Zhang; Xi Yang; Hongcheng Zhu; Baixia Yang; Jing Cai; Hongyan Cheng; Jianxin Ma; Jing Lu; Liangliang Zhan; Jia Liu; Zheming Liu; Liping Xu; Xinchen Sun
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

10.  Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma.

Authors:  Tomoko Yamagishi; Katsuhiko Shimizu; Nobuaki Ochi; Hiromichi Yamane; Isao Irei; Yoshito Sadahira; Nagio Takigawa; Mikio Oka; Masao Nakata
Journal:  Diagn Pathol       Date:  2014-05-29       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.